Comparative analysis of the change of bone tissue metabolism condition and cytokine profiles in patients with endoprosthesis instability after primary knee arthroplasty

Abstract

Aim. To define relations between serum concentrations of sRANKL and BMP-2, IL-1β, TNFα, IL-4 as well as their role in endoprosthesis instability pathogenesis in patients following primary knee arthroplasties.

Materials and Methods. 80 patients were retrospectively divided into 2 groups: there were 40 patients with osteolysis and aseptic instabilities of knee endoprosthesises that had developed before 12 months after the surgery in the 1^st group; the 2^nd group was made up of 40 patients with implantat-associated inflammations that had developed in 4 weeks to 12 months after primary knee arthroplasties. 20 volunteer donors made up the control group. The enzyme-linked assay was used to define serum content of sRANKL (pg/ml, Biomedica, Austria), BMP-2 (pg/ml, Ray Bio, USA), cytokines TNFα (pg/ml), IL-1β (pg/ml) and IL-4 (pg/ml) (Vector-Best, CJSC, Novosibirsk, Russian Federation). The comparative analysis of statistically significant indicants was performed defining Spearman rank correlation coefficient.

Results. Positive statistically valid relations of average force between concentrations of sRANKL and BMP-2, TNFα, IL-4 were found in patients of the first group in 1 month after surgeries. In 12 months positive relations of the parameters under study subsisted although the relation with IL-4 absented. The emerging of moderate negative statistically significant relations of sRANKL with BMP-2 and TNFα was observed in patients of the 2^nd group in 1 month after surgeries. In 12 months negative relations of average force between sRANKL and BMP-2 subsisted, also new moderate relations emerged: negative relation of BMP-2 with IL-1β as well as positive of sRANKL with IL-1β and TNFα, IL-1β with IL-4.

Conclusion. We found that the disorder of metabolic processes in bone tissue surrounding the implantat with the predominance of osteoclastogenesis activating pro-inflammatory cytokines might be the pathogenic factors of endoprosthesis instability development in patients following primary knee arthroplasty.

Keywords

knee joint / primary arthroplasty / endoprosthesis instability / bone tissue metabolism / cytokines

References

[1] Sagalovsky S., Schönert M. Cellular and Molecular Mechanisms of Development of Aseptic Instability of Hip Im-plant. Trauma. 2012;13(1):153-60. (In Russ).

[2] Сагаловски С., Шенерт М. Клеточно-молеку-лярные механизмы развития асептической нестабильности эн-допротеза сустава // Травма. 2012. Т. 13, №1. С. 153-160.

[3] Tikhilov RM, Shapovalov VM. Rukovodstvo po endoprotezirovaniyu tazobedrennogo sustava. Sankt-Peterburg; 2008.

[4] Тихилов Р.М., Шаповалов В.М. Руководство по эндопротезированию тазобедренного сустава. СПб.; 2008.

[5] Naumenko ZS, Chepeleva MV, Godovykh NV. Cytokines and microbiocenosis in predicting the postoperative period course in patients with periprosthetic infection of the hip joint after removal of the infected implant. Novosti Khi-rurgii. 2017; 25(6):605-12. doi:10.18484/2305-0047. 2017.6.605 (In Russ).

[6] Науменко З.С., Чепелева М.В., Годовых М.В. Цитокины и микробиоценоз в прогнозировании течения после-операционного периода у пациентов с перипротезной инфекцией тазобедренного сустава после удаления инфицированного эндопротеза // Новости хирургии. 2017. Т. 25, №6. С. 605-612. doi:10.18484/2305-0047.2017.6.605

[7] Smirnov AV, Rumyantsev ASh. Bone tissue function and structure under normal and pathological condition. Message II. Nephrology. 2015;19(1):8-17. (In Russ).

[8] Смирнов А.В., Румянцев А.Ш. Строение и функции костной ткани в норме и при патологии. Сообщение II // Нефрология. 2015. Т. 19, №1. С. 8-17.

[9] Nigmatullin RT, Shcherbakov DA, Musina LM, et al. Some aspects of clinical use of bone and cartilage allografts. Bashkortostan Medical Journal. 2012;7(4):78-83. (In Russ).

[10] Нигматуллин Р.Т., Щербаков Д.А., Мусина Л.М., и др. Некоторые аспекты применения костных и хрящевых аллотрансплантатов // Медицинский вестник Башкортостана. 2012. Т. 7, №4. С. 78-83.

[11] Dmitriyeva LA, Lebedev VF, Korshunova EYu. Oslozhneniya pri endoprotezirovanii tazobedrennogo sustava i sposoby ikh prognozirovaniya (obzor literatury). Byulleten’ Vostochno-Sibirskogo Nauch-nogo Tsentra Sibirskogo Otdeleniya Rossiyskoy Akademii Meditsinskikh Nauk. 2013;2-1(90):153-8. (In Russ).

[12] Дмитриева Л.А., Лебедев В.Ф., Коршунова Е.Ю. Осложнения при эндопротезировании тазобедренного суста-ва и способы их прогнозирования (обзор литературы) // Бюллетень Восточно-Сибирского научного центра сибирского отделения Российской академии медицинских наук. 2013. №2-1 (90). С. 153-158.

[13] Rozhnova OM, Prokhorenko VM, Sadovoy MA, et al. Pathogenic factors of aseptic loosening of joint implants (re-view). Siberian Medical Journal. 2015; 35(5):84-9. (In Russ).

[14] Рожнова О.М., Прохоренко В.М., Садовой М.А., и др. Патогенетические факторы формирования асептиче-ской нестабильности эндопротезов суставов (обзор литературы) // Сибирский научный медицинский журнал. 2015. Т. 35, №5. С. 84-89.

[15] Mertens MT, Singh JA. Biomarkers in Arthroplasty: A Systematic Review. The Open Orthopaedics Journal. 2011;5:92-105. doi:10.2174/1874325001 105010092

[16] Mertens M.T., Singh J.A. Biomarkers in Arthroplasty: A Systematic Review // The Open Orthopaedics Journal. 2011. Vol. 5. Р. 92-105. doi:10.2174/ 1874325001105010092

[17] Gladkova EV, Karyakina EV, Tsareva EE, et al. The peculiarities of bone and cartilage tissue remodeling in patients after hip joint replacement. Saratov Journal of Medical Scientific Research. 2017;13(3):723-7. (In Russ).

[18] Гладкова Е.В., Карякина Е.В., Царева Е.Е., и др. Особенности ремоделирования костной и хрящевой ткани у пациентов после эндопротезирования тазобедренного сустава // Саратовский научно-медицинский журнал. 2017. Т. 13, №3. С. 723-727.

[19] Cрepeleva MV, Cрegurov OK, Kuznecova EI, et al. Parameters of immunity in patients with aseptic instability of knee joints. Clinical Laboratory Diagnostics. 2014;8:18-21. (In Russ).

[20] Чепелева М.В., Чегуров О.К., Кузнецова Е.И., и др. Показатели иммунитета у пациентов с асептической не-стабильностью коленного сустава // Клиническая лабораторная диагностика. 2014. № 8. С.18-21.

[21] Amarasekara DS, Yu J, Rho J. Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseas-es. Journal of Immunology Research. 2015;2015:832127. doi.org/10.1155/ 2015/832127

[22] Amarasekara D.S., Yu J., Rho J. Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Dis-eases // Journal of Immunology Research. 2015. Vol. 2015. P. 832127. doi:10.1155/ 2015/832127

[23] Chebotar IV. Mechanisms of antibiofilm immunity. Annals of the Russian Academy of Medical Sciences. 2012;(2):22-9. (In Russ).

[24] Чеботарь И.В. Механизмы антибиопленочного иммунитета // Вестник РАМН. 2012. №2. С. 22-29.

[25] Rozhnova OM, Falameeva OV, Sadovoy MA. Pathophysiology of bone tissue in osteoporosis (review). International Journal of Applied and Fundamental Research. 2015;(9):666-9. (In Russ).

[26] Рожнова О.М., Фаламеева О.В., Садовой М.А. Патофизиология костной ткани при остеопорозе (обзор лите-ратуры) // Международный журнал прикладных и фундаментальных исследований. 2015. №9. С. 666-669.

RIGHTS & PERMISSIONS

Galashina E.A., Ulyanov V.Y., Gladkova E.V., Shpinyak S.P., Bondarenko A.S.